 INmune Bio, Inc. NASDAQ:INMB Q2 2022 Earnings Conference Call August 3, 2022 4:30 PM ET Company Participants David Moss Co-Founder and Chief Financial Officer RJ Tesi Co-Founder and Chief Executive Officer Mark Lowdell Co-Founder and Chief Scientific Officer Conference Call Participants Tom Shrader BTIG William Wood B. Riley Daniel Carlson TW Research Group Operator Greetings, and welcome to the INmune Bio Second Quarter 2022 Earnings Call. 